CS logo
small CS logo
Medical University Reaviz

Samara, Russian Federation
Частный университет в Самаре

About Medical University Reaviz


Медицинский университет «Реавиз» — частный медицинский университет, реализующий высшее и последипломное образование в городах Самара, Москва, Санкт-Петербург, Саратов. Имеет представительство в г. Бургас. Основан в 1993 году. Выдаёт дипломы и свидетельства о медицинском образовании государственного образца.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Shire
5
Celgene
3
Janssen Research & Development, LLC
3
Genentech, Inc.
2
Pfizer
2
BeyondSpring Pharmaceuticals Inc.
1
Catalysis SL
1
Eiger BioPharmaceuticals
1
Kangen Pharmaceuticals, Inc
1
Mabscale, LLC
1
Total Rows: 10

Clinical Trials at Medical University Reaviz


During the past decade, Medical University Reaviz conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1133111133110000110000000000223311Started TrialsCompleted Trails20162017201820192020202120222023051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
2016-02-24
2021-12-30
Completed
264
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
2017-02-03
2021-05-10
Completed
319
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-02-09
2020-10-23
Terminated
380
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2018-03-07
2024-06-28
Recruiting
600
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2018-06-27
2025-06-24
Recruiting
485
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Medical University Reaviz" #1 sponsor was "Shire" with 5 trials, followed by "Celgene" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsShire: 5Shire: 5Celgene: 3Celgene: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Genentech, Inc.: 2Genentech, Inc.: 2Pfizer: 2Pfizer: 2BeyondSpringPharmaceuticals Inc.: 1BeyondSpringPharmaceuticals Inc.: 1Catalysis SL: 1Catalysis SL: 1Eiger BioPharmaceuticals: 1Eiger BioPharmaceuticals: 1Kangen Pharmaceuticals, Inc: 1Kangen Pharmaceuticals, Inc: 1Mabscale, LLC: 1Mabscale, LLC: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Medical University Reaviz


According to Clinical.Site data, the most researched conditions in "Medical University Reaviz" are "Ulcerative Colitis" (7 trials), "Crohn's Disease" (5 trials), "Crohn Disease" (3 trials), "Advanced Malignancies" (1 trials) and "Chemotherapy-induced Neutropenia" (1 trials). Many other conditions were trialed in "Medical University Reaviz" in a lesser frequency.

Clinical Trials Intervention Types at Medical University Reaviz


Most popular intervention types in "Medical University Reaviz" are "Drug" (18 trials), "Other" (6 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "Guselkumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Medical University Reaviz


The vast majority of trials in "Medical University Reaviz" are 20 trials for "All" genders.

Clinical Trials Status at Medical University Reaviz


Currently, there are NaN active trials in "Medical University Reaviz". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Medical University Reaviz, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Medical University Reaviz, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 2: 9Phase 2: 9Phase 1: 2Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 5Active, not recruiting: 5Recruiting: 3Recruiting: 3Terminated: 3Terminated: 3